A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
Eli Lilly and Company
Eli Lilly and Company
Massachusetts General Hospital
Novartis
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
CRISPR Therapeutics
Fred Hutchinson Cancer Center
City of Hope Medical Center
Takeda
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Pacylex Pharmaceuticals
Merck Sharp & Dohme LLC
Gamida Cell ltd